With demonstrated safety and efficacy for use up to a maximum of 3 days, Onsior® (robenacoxib) should be top of mind for your spay/neuter patients.1
When administered postoperatively for a maximum of 3 days, Onsior Tablets for Cats have been shown to be effective and well-tolerated.
*Cats may have experienced more than one of these signs during the study.
*Cats may have experienced more than one type or occurrence of an event during the study.
**One Onsior cat suffered an anesthetic-related death.
***Semiconscious cat fully recovered.
The safety study supports the safe use for up to a maximum of 3 days.
Onsior® (robenacoxib) injection is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration in cats ≥ 4 months of age; for up to a maximum of 3 days.
Onsior® (robenacoxib) Tablets for Cats are indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration in cats ≥ 5.5 lbs (2.5 kg) and ≥ 4 months of age; for up to a maximum of 3 days.
Do not use in cats that have hypersensitivity to robenacoxib or known intolerance to NSAIDs. All cats should undergo a thorough history and exam before initiation of NSAID therapy. Do not administer Onsior in conjunction with any other NSAID or corticosteroid. Owners should be advised to observe for signs of potential drug toxicity. Click here for full prescribing information.
Onsior Injection: For subcutaneous use in cats only. The most common adverse reactions were incision site bleeding, incision site infection, vomiting, lethargy, and anorexia.
Onsior Tablet: The most common adverse events are anorexia, depression, vomiting, elevated BUN, elevated creatinine, and renal insufficiency/failure.
© 2017 Eli Lilly and Company or its affiliates. Onsior, Elanco and the diagonal bar logo are trademarks of Eli Lilly and Company or its affiliates. USCAHMUL01907(1)